(Q40256154)

18 September 2017

1 reference

title

Pharmacology, clinical efficacy, and adverse effects of piroxicam, a new nonsteroidal anti-inflammatory agent (English)

1 reference

18 September 2017

1 reference

Dahl SL

1

1 reference

18 September 2017

Ward JR

series ordinal

2

1 reference

18 September 2017

language of work or name

English

0 references

publication date

1 March 1982

1 reference

18 September 2017

1 reference

18 September 2017

volume

2

1 reference

18 September 2017

issue

2

1 reference

18 September 2017

page(s)

80-90

1 reference

Pharmacokinetics of piroxicam, a new nonsteroidal anti-inflammatory agent, under fasting and postprandial states in man

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1982.TB03178.X

Piroxicam Pharmacokinetics in Man: Aspirin and Antacid Interaction Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1982.TB03178.X

A comparison of the carrageenan edema test and ultraviolet light-induced erythema test as predictors of the clinical dose in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1982.TB03178.X

The effect of piroxicam on platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1982.TB03178.X

Piroxicam, a potent inhibitor of prostaglandin production in cell culture. Structure-activity study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1982.TB03178.X

A crossover clinical trial of piroxicam, indomethacin and ibuprofen in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1982.TB03178.X

Piroxicam in the Treatment of Osteoarthrosis: A Multicentre Study in General Practice Involving 1218 Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1982.TB03178.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1982.TB03178.X

Piroxicam in the Treatment of Acute Gout: A Multicentre Open Study in General Practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1982.TB03178.X

Comparative study with piroxicam and ibuprofen versus placebo in the supportive treatment of minor sports injuries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1982.TB03178.X

A method for estimating the probability of adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1982.TB03178.X

Aspirin-induced depression of renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1982.TB03178.X

Elevated urinary prostaglandins and the effects of aspirin on renal function in lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1982.TB03178.X

Apparent acute renal failure associated with therapeutic aspirin and ibuprofen administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1982.TB03178.X

Reduction of renal function by newer nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1982.TB03178.X

10.1002/J.1875-9114.1982.TB03178.X

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference